from Reuters: Health News http://ift.tt/2CDArfr
Novo's pioneering diabetes pill impresses in first big study
COPENHAGEN/LONDON (Reuters) - The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.
from Reuters: Health News http://ift.tt/2CDArfr
from Reuters: Health News http://ift.tt/2CDArfr
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment